Xin Lu

3.4k total citations · 1 hit paper
116 papers, 2.4k citations indexed

About

Xin Lu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xin Lu has authored 116 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 27 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Xin Lu's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (11 papers). Xin Lu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (11 papers). Xin Lu collaborates with scholars based in China, United States and United Kingdom. Xin Lu's co-authors include Xinting Sang, Yilei Mao, Huayu Yang, Haitao Zhao, Shouxian Zhong, Jinhong Duan, Xian‐Da Yang, Yiyao Xu, Hongbing Zhang and Jiefu Huang and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Nature Communications.

In The Last Decade

Xin Lu

110 papers receiving 2.3k citations

Hit Papers

Evolutionary patterns and... 2023 2026 2024 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis
    2023 92 citations Shitao Jiang, Y. Liu et al. International Journal of Surgery profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xin Lu 945 514 434 412 394 116 2.4k
Guihua Chen 556 0.6× 492 1.0× 313 0.7× 449 1.1× 592 1.5× 125 2.2k
Federica Genovese 808 0.9× 269 0.5× 353 0.8× 451 1.1× 314 0.8× 128 3.0k
Lu Cao 720 0.8× 609 1.2× 526 1.2× 161 0.4× 121 0.3× 157 2.4k
Ruchi Bansal 797 0.8× 677 1.3× 267 0.6× 656 1.6× 660 1.7× 85 3.1k
Nan Jiang 1.5k 1.6× 889 1.7× 505 1.2× 399 1.0× 143 0.4× 188 3.6k
Sébastien Lepreux 633 0.7× 336 0.7× 227 0.5× 652 1.6× 652 1.7× 105 3.2k
Václav Liška 1.3k 1.4× 964 1.9× 852 2.0× 295 0.7× 230 0.6× 194 3.1k
Shusen Zheng 826 0.9× 845 1.6× 235 0.5× 338 0.8× 265 0.7× 117 3.0k
Masaaki Takamura 870 0.9× 542 1.1× 332 0.8× 402 1.0× 497 1.3× 100 2.2k
Daniel C. Adelman 803 0.8× 756 1.5× 269 0.6× 359 0.9× 124 0.3× 78 3.1k

Countries citing papers authored by Xin Lu

Since Specialization
Citations

This map shows the geographic impact of Xin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Lu more than expected).

Fields of papers citing papers by Xin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Lu. The network helps show where Xin Lu may publish in the future.

Co-authorship network of co-authors of Xin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Lu. A scholar is included among the top collaborators of Xin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Lu. Xin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Xin, et al.. (2024). Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma. Journal of Controlled Release. 378. 849–863. 1 indexed citations
3.
Zhu, Qianhui, Qi Chen, Shenghan Gao, et al.. (2024). PIPdb: a comprehensive plasmid sequence resource for tracking the horizontal transfer of pathogenic factors and antimicrobial resistance genes. Nucleic Acids Research. 53(D1). D169–D178. 3 indexed citations
4.
Gao, Yanxia, et al.. (2023). Establishment and evaluation of animal models of sepsis-associated encephalopathy. World Journal of Emergency Medicine. 14(5). 349–349. 9 indexed citations
5.
Jiang, Shitao, Y. Liu, Han Zheng, et al.. (2023). Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis. International Journal of Surgery. 109(9). 2774–2783. 92 indexed citations breakdown →
6.
Gao, Yanxia, et al.. (2023). The association between levosimendan and mortality in patients with sepsis or septic shock: a systematic review and meta-analysis. European Journal of Emergency Medicine. 31(2). 90–97. 4 indexed citations
7.
8.
Lu, Xin, Xue Wang, Yanxia Gao, et al.. (2022). Norepinephrine Use in Cardiogenic Shock Patients is Associated with Increased 30 Day Mortality. ESC Heart Failure. 9(3). 1875–1883. 15 indexed citations
9.
Li, Zhenpeng, et al.. (2022). The Establishment and Application of a Kraken Classifier for <i>Salmonella</i> Plasmid Sequence Prediction. China CDC Weekly. 4(49). 1110–1116. 1 indexed citations
10.
Bian, Jin‐Song, Junyu Long, Xu Yang, et al.. (2021). Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma. Annals of Translational Medicine. 9(9). 765–765. 7 indexed citations
11.
Lu, Xin, Wei Han, Yanxia Gao, et al.. (2021). Efficacy and safety of corticosteroids in immunocompetent patients with septic shock. World Journal of Emergency Medicine. 12(2). 124–124. 1 indexed citations
12.
Gao, Yanxia, et al.. (2021). Family intervention for delirium for patients in the intensive care unit: A systematic meta-analysis. Journal of Clinical Neuroscience. 96. 114–119. 21 indexed citations
13.
Xiao, Xinyue, Yueting Li, Xu Jiang, et al.. (2020). EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis. Journal of Autoimmunity. 108. 102404–102404. 51 indexed citations
14.
Cui, Jianwei, Yinyan Xu, Yibo Wang, et al.. (2018). Efficacy of initial haemopurification strategy for acute paraquat poisoning in adults: study protocol for a randomised controlled trial (HeSAPP). BMJ Open. 8(6). e021964–e021964. 5 indexed citations
15.
Zhou, Xu, et al.. (2018). Anxa2 attenuates osteoblast growth and is associated with hip BMD and osteoporotic fracture in Chinese elderly. PLoS ONE. 13(3). e0194781–e0194781. 18 indexed citations
16.
Hu, Yan, Junwen Duan, Bangrong Cao, et al.. (2015). Selection of a novel DNA thioaptamer against HER2 structure. Clinical & Translational Oncology. 17(8). 647–656. 20 indexed citations
17.
Liu, Zhe, Jinhong Duan, Yongmei Song, et al.. (2012). Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro. Journal of Translational Medicine. 10(1). 148–148. 148 indexed citations
18.
Sun, Yongliang, Huayu Yang, Yilei Mao, et al.. (2011). Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. Journal of Gastroenterology and Hepatology. 26(7). 1207–1212. 47 indexed citations
19.
Mao, Yilei, Huayu Yang, Haifeng C. Xu, et al.. (2010). Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 59(12). 1687–1693. 209 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guihua Chen Breakdown of academic impact, for papers by Federica Genovese Breakdown of academic impact, for papers by Lu Cao Breakdown of academic impact, for papers by Ruchi Bansal Breakdown of academic impact, for papers by Nan Jiang Breakdown of academic impact, for papers by Sébastien Lepreux Breakdown of academic impact, for papers by Václav Liška Breakdown of academic impact, for papers by Shusen Zheng Breakdown of academic impact, for papers by Masaaki Takamura Breakdown of academic impact, for papers by Daniel C. Adelman
Rankless by CCL
2026